Clinical Trial Update: Comparing Ginkgo Biloba Pills and Placebo in the Treatment of Coronary Heart Disease With Impaired Glucose Regulation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares Ginkgo biloba extract pills to placebo for treating coronary heart disease in individuals with impaired glucose regulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Ginkgo biloba extract (Ginkgo biloba extract)

Snippet

Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences | Conditions: Randomized Controlled Trial, Ginkgo Biloba Extract | Phase 4 | Status: UNKNOWN